These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16219725)

  • 41. Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin.
    Houle JM; Strong HA
    Retina; 2002 Dec; 22(6):691-7. PubMed ID: 12476093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration.
    Singh CN; Saperstein DA
    Retina; 2008 Jun; 28(6):789-93. PubMed ID: 18536593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Choroidal infarction following photodynamic therapy with verteporfin.
    Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faÿsse M; Coscas G; Gross NE; Yannuzzi LA
    Arch Ophthalmol; 2005 Aug; 123(8):1149-53. PubMed ID: 16087856
    [No Abstract]   [Full Text] [Related]  

  • 44. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hot spots after photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Battaglia Parodi M; Da Pozzo S
    Retina; 2002 Oct; 22(5):671-3. PubMed ID: 12441743
    [No Abstract]   [Full Text] [Related]  

  • 46. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H; Abrams P
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
    Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
    Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic therapy combined with intravitreal bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Lazić R; Gabrić N; Dekaris I; Gavrić M; Bosnar D
    Coll Antropol; 2007 Jan; 31 Suppl 1():71-5. PubMed ID: 17469756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
    Van de Moere A; Sandhu SS; Kak R; Mitchell KW; Talks SJ
    Ophthalmology; 2005 Nov; 112(11):1896-903. PubMed ID: 16214216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profound choroidal hypoperfusion after combined photodynamic therapy and intravitreal triamcinolone acetonide.
    Blaha GR; Wertz FD; Marx JL
    Ophthalmic Surg Lasers Imaging; 2008; 39(1):6-11. PubMed ID: 18254344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large submacular hemorrhages after verteporfin therapy.
    Do DV; Bressler NM; Bressler SB
    Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous diclofenac as prophylactic treatment for verteporfin-associated low back pain.
    Theelen T; Hoyng CB
    Eur J Ophthalmol; 2008; 18(5):805-8. PubMed ID: 18850562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia.
    Srivastava SK; Sternberg P
    Retina; 2002 Oct; 22(5):669-71. PubMed ID: 12441742
    [No Abstract]   [Full Text] [Related]  

  • 56. Nonarteritic anterior ischemic optic neuropathy after photodynamic therapy for choroidal neovascularization.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2004; 48(4):424-6. PubMed ID: 15295679
    [No Abstract]   [Full Text] [Related]  

  • 57. Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia.
    Ohno-Matsui K; Moriyama M; Hayashi K; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1363-6. PubMed ID: 16523294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Verteporfin infusion-associated pain.
    Borodoker N; Spaide RF; Maranan L; Murray J; Freund KB; Slakter JS; Sorenson JA; Yannuzzi LA; Guyer DR; Fisher YL
    Am J Ophthalmol; 2002 Feb; 133(2):211-4. PubMed ID: 11812424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anaphylactoid reaction after verteporfin therapy.
    Doshi AB; Moshfeghi DM; Jack RL
    Am J Ophthalmol; 2005 Nov; 140(5):936-7. PubMed ID: 16310483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bilateral punctal-canalicular stenosis following photodynamic therapy for choroidal neovascularization.
    Yim JF; Crofts KP
    Cutan Ocul Toxicol; 2011 Mar; 30(1):78-9. PubMed ID: 20950246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.